--- title: "We're Not Very Worried About Bright Minds Biosciences' (CSE:DRUG) Cash Burn Rate" type: "News" locale: "en" url: "https://longbridge.com/en/news/291278467.md" description: "Bright Minds Biosciences (CSE:DRUG) maintains a comfortable cash position with CA$310m in reserves and no debt, yielding a long runway despite a 379% surge in annual cash burn to CA$20m. This burn rate represents only 2.3% of its market cap, suggesting easy access to capital via equity or debt. Analysts forecast the company will reach free cash flow breakeven before depleting reserves, leading the authors to remain unconcerned about its current spending trajectory." datetime: "2026-06-30T11:55:40.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/291278467.md) - [en](https://longbridge.com/en/news/291278467.md) - [zh-HK](https://longbridge.com/zh-HK/news/291278467.md) --- # We're Not Very Worried About Bright Minds Biosciences' (CSE:DRUG) Cash Burn Rate There's no doubt that money can be made by owning shares of unprofitable businesses. By way of example, **Bright Minds Biosciences** (CSE:DRUG) has seen its share price rise 169% over the last year, delighting many shareholders. Nonetheless, only a fool would ignore the risk that a loss making company burns through its cash too quickly. So notwithstanding the buoyant share price, we think it's well worth asking whether Bright Minds Biosciences' cash burn is too risky. For the purpose of this article, we'll define cash burn as the amount of cash the company is spending each year to fund its growth (also called its negative free cash flow). We'll start by comparing its cash burn with its cash reserves in order to calculate its cash runway. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. ## Does Bright Minds Biosciences Have A Long Cash Runway? A company's cash runway is the amount of time it would take to burn through its cash reserves at its current cash burn rate. As at March 2026, Bright Minds Biosciences had cash of CA$310m and no debt. In the last year, its cash burn was CA$20m. That means it had a cash runway of very many years as of March 2026. Notably, however, analysts think that Bright Minds Biosciences will break even (at a free cash flow level) before then. If that happens, then the length of its cash runway, today, would become a moot point. You can see how its cash balance has changed over time in the image below. CNSX:DRUG Debt to Equity History June 30th 2026 View our latest analysis for Bright Minds Biosciences ## How Is Bright Minds Biosciences' Cash Burn Changing Over Time? Bright Minds Biosciences didn't record any revenue over the last year, indicating that it's an early stage company still developing its business. So while we can't look to sales to understand growth, we can look at how the cash burn is changing to understand how expenditure is trending over time. Remarkably, it actually increased its cash burn by 379% in the last year. We certainly hope for shareholders' sake that the money is well spent, because that kind of expenditure increase always makes us nervous. Clearly, however, the crucial factor is whether the company will grow its business going forward. So you might want to take a peek at how much the company is expected to grow in the next few years. ## How Easily Can Bright Minds Biosciences Raise Cash? While Bright Minds Biosciences does have a solid cash runway, its cash burn trajectory may have some shareholders thinking ahead to when the company may need to raise more cash. Issuing new shares, or taking on debt, are the most common ways for a listed company to raise more money for its business. One of the main advantages held by publicly listed companies is that they can sell shares to investors to raise cash and fund growth. By comparing a company's annual cash burn to its total market capitalisation, we can estimate roughly how many shares it would have to issue in order to run the company for another year (at the same burn rate). Bright Minds Biosciences' cash burn of CA$20m is about 2.3% of its CA$879m market capitalisation. That means it could easily issue a few shares to fund more growth, and might well be in a position to borrow cheaply. ## How Risky Is Bright Minds Biosciences' Cash Burn Situation? It may already be apparent to you that we're relatively comfortable with the way Bright Minds Biosciences is burning through its cash. In particular, we think its cash runway stands out as evidence that the company is well on top of its spending. While we must concede that its increasing cash burn is a bit worrying, the other factors mentioned in this article provide great comfort when it comes to the cash burn. One real positive is that analysts are forecasting that the company will reach breakeven. Looking at all the measures in this article, together, we're not worried about its rate of cash burn; the company seems well on top of its medium-term spending needs. On another note, we conducted an in-depth investigation of the company, and identified **5 warning signs for Bright Minds Biosciences** (3 don't sit too well with us!) that you should be aware of before investing here. Of course **Bright Minds Biosciences may not be the best stock to buy**. So you may wish to see this **free** collection of companies boasting high return on equity, or this list of stocks with high insider ownership. ### Valuation is complex, but we're here to simplify it. Discover if Bright Minds Biosciences might be undervalued or overvalued with our detailed analysis, featuring **fair value estimates, potential risks, dividends, insider trades, and its financial condition.** Access Free Analysis ### Related Stocks - [DRUG.US](https://longbridge.com/en/quote/DRUG.US.md) ## Related News & Research - [ADAR1 Capital Management LLC Has $2.47 Million Stock Position in Bright Minds Biosciences Inc. $DRUG](https://longbridge.com/en/news/294165780.md) - [Quantum BioPharma settles CAD 123,487 debt with 30,948 shares at CAD 3.99 each](https://longbridge.com/en/news/294300672.md) - [One Nerds on Site Insider Raised Stake By 66% In Previous Year](https://longbridge.com/en/news/293952540.md) - [Etruscus Resources plans up to $700,000 private placement of flow-through, non-flow-through units](https://longbridge.com/en/news/294396243.md) - [Trillion Energy Announces Name Change and New Trading Symbol | TRLEF Stock News](https://longbridge.com/en/news/294264907.md)